Working Groups

Latest News

Travel Grant Deadline!

Only 2 weeks left to submit abstracts / apply for ISAC Travel Grants ...

Read More
Impact Factors Increase!

The 2018 Impact Factors for both IJAA and JGAR have increased!

Read More

Membership

Current Officers

Chair

Jason Roberts

j.roberts2@uq.edu.au

Vice-Chair

Stefan Hagel

Stefan.Hagel@med.uni-jena.de

Secretary

Hafiz Abdul-Aziz

mohd.abdulaziz1@uq.net.au

Treasurer

Despoina Koulenti

d.koulenti@uq.edu.au

All Members

Massimo Antonelli (Italy)
Georgios Dimopoulos (Greece)
Hakan Erdem (Turkey)
Igor Karpov (Belarus)
Despoina Koulenti (Greece)
Alain Lepape (France)
Jeffrey Lipman (Australia)
Jose-Artur Paiva (Portugal)
Mathias Pletz (Germnay)
Rosana Richtmann (Brazil)
Vladimir Rudnov (Russia)
Kordo Saeed (UK)

How to Join

Members of an ISAC Member Society are eligible to join any of our Working Groups. If you are a member and would like to join this group, please contact the Chairperson and Secretary (if applicable).

Aims and Objectives

Infections in the intensive care unit (ICU) represent the nosocomial infections of the near future as it is predicted that hospitals of the future will be transformed into massive ICUs and other units providing increased levels of care. Generally, patients who are transferred from the ICU to hospital wards are colonised with antimicrobial-resistant bacteria, providing a focus for spread and colonization of the whole hospital. Thus, today’s ICUs are of major concern regarding both prevention and therapy of the nosocomial infections arising in their environment. Ventilation associated pneumonia (VAP) and central catheter-associated infections represent the majority of ICU infections, with mortality rates exceeding 30%. The principle causes are multi-resistant strains of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella species producing ESBLs, MRSA and VRE strains.

This Working Group aims to:

  • Enhance the epidemiological surveillance of nosocomial ICU infections
  • Promote antibiotic resistant surveillance in ICUs
  • Evaluate therapeutic decisions in the ICU. These include antibiotic rotation, restriction and de-escalation policies, in order to prevent and/or reduce resistance rates by applying well-organised protocols
  • Evaluate the validity of surveillance cultures as a guide to empirical antimicrobial therapy
  • Promote the implementation of “hand-hygiene protocols”.

Presentations

24-27 Nov 2017 30th International Congress of Chemotherapy & Infection (ICC)

Projects / Publications

Consensus Statement on Antimicrobial Therapeutic Drug Monitoring in Critically Ill Patients
The Screening of Antifungal Exposure in ICU (SAFE-ICU) Study
2017 Infections in the ICU & Sepsis Annual Report 2017

Links

Last updated: July 9th-2019